• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary.

作者信息

Chakravarthy U, Williams M

机构信息

Department of Ophthalmology, Queen's University Belfast, Belfast, UK.

出版信息

Eye (Lond). 2013 Dec;27(12):1429-31. doi: 10.1038/eye.2013.233. Epub 2013 Oct 25.

DOI:10.1038/eye.2013.233
PMID:24158023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3869519/
Abstract
摘要

相似文献

1
The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary.英国皇家眼科医学院年龄相关性黄斑变性指南：执行摘要。
Eye (Lond). 2013 Dec;27(12):1429-31. doi: 10.1038/eye.2013.233. Epub 2013 Oct 25.
2
The Royal College of Ophthalmologists Commissioning guidelines on age macular degeneration: executive summary.皇家眼科医学院年龄相关性黄斑变性委托指南：执行摘要
Eye (Lond). 2022 Nov;36(11):2078-2083. doi: 10.1038/s41433-022-02095-2. Epub 2022 May 27.
3
The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary.皇家眼科医学院视网膜静脉阻塞指南：执行摘要。
Eye (Lond). 2015 Dec;29(12):1633-8. doi: 10.1038/eye.2015.164. Epub 2015 Aug 28.
4
[New aspects in the management of exudative age-related macular degeneration - current position of the Retinological Society, the German Ophthalmology Society and the Professional Union of Ophthalmologists in Germany].渗出性年龄相关性黄斑变性的治疗新进展——德国视网膜学会、德国眼科学会及德国眼科医师专业协会的当前立场
Klin Monbl Augenheilkd. 2009 May;226(5):388-95. doi: 10.1055/s-0028-1109432. Epub 2009 Jun 8.
5
Local anaesthesia for ophthalmic surgery--new guidelines from the Royal College of Anaesthetists and the Royal College of Ophthalmologists.眼科手术的局部麻醉——麻醉医师皇家学院和眼科医师皇家学院的新指南
Eye (Lond). 2012 Jun;26(6):897-8. doi: 10.1038/eye.2012.82. Epub 2012 Apr 27.
6
[New French guidelines: Diagnosis and management of age-related macular degeneration. A work, a story...].[法国新指南：年龄相关性黄斑变性的诊断与管理。一项工作，一个故事……]
J Fr Ophtalmol. 2013 Apr;36(4):297-8. doi: 10.1016/j.jfo.2013.03.003.
7
Age-related macular degeneration: treating the whole patient.年龄相关性黄斑变性：治疗整个患者。
Can J Ophthalmol. 2005 Jun;40(3):389-91. doi: 10.1016/S0008-4182(05)80082-1.
8
[Supplements in age-related macular degeneration: recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists--October 2014].[年龄相关性黄斑变性的补充剂：德国眼科学会、德国视网膜学会和德国眼科医生专业协会的建议——2014年10月]
Ophthalmologe. 2015 Jan;112(1):35-40. doi: 10.1007/s00347-014-3220-z.
9
Guidance on patient safety in ophthalmology from the Royal College of Ophthalmologists.皇家眼科学院关于眼科患者安全的指南。
Eye (Lond). 2009 Dec;23(12):2143-51. doi: 10.1038/eye.2009.168.
10
Comment on 'The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary'.关于《皇家眼科医学院视网膜静脉阻塞指南：执行摘要》的评论
Eye (Lond). 2015 Dec;29(12):1631-2. doi: 10.1038/eye.2015.219. Epub 2015 Oct 30.

引用本文的文献

1
Smaller-incision new-generation implantable miniature telescope in late-stage age-related macular degeneration: 6 month outcomes.小切口新一代可植入式微型望远镜治疗晚期年龄相关性黄斑变性：6个月的结果
Heliyon. 2024 Dec 15;11(1):e41116. doi: 10.1016/j.heliyon.2024.e41116. eCollection 2025 Jan 15.
2
Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB) Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III Study.生物类似药雷珠单抗（OPTIMAB）与原研雷珠单抗治疗新生血管性（湿性）年龄相关性黄斑变性患者的疗效和安全性：一项双盲、随机、多中心、III期研究
Clin Ophthalmol. 2024 Oct 29;18:3071-3081. doi: 10.2147/OPTH.S488866. eCollection 2024.
3
Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration.残留视网膜积液对新生血管性年龄相关性黄斑变性治疗效果的影响。
Br J Ophthalmol. 2025 Feb 24;109(3):307-315. doi: 10.1136/bjo-2024-325640.
4
Anatomical and Functional Outcomes with Prompt versus Delayed Initiation of Anti-VEGF in Exudative Age-Related Macular Degeneration.湿性年龄相关性黄斑变性中抗血管内皮生长因子治疗早期与延迟起始的解剖学和功能结局
J Clin Med. 2023 Dec 25;13(1):111. doi: 10.3390/jcm13010111.
5
Prospective, Longitudinal Pilot Study: Daily Self-Imaging with Patient-Operated Home OCT in Neovascular Age-Related Macular Degeneration.前瞻性纵向试点研究：在新生血管性年龄相关性黄斑变性患者中使用患者操作的家用光学相干断层扫描进行每日自我成像。
Ophthalmol Sci. 2021 Jun 26;1(2):100034. doi: 10.1016/j.xops.2021.100034. eCollection 2021 Jun.
6
Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.接受抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性患者的停药模式。
Indian J Ophthalmol. 2022 Jun;70(6):2065-2070. doi: 10.4103/ijo.IJO_3066_21.
7
Findings of uncertain significance by optical coherence tomography (OCT) as prognostic factors in neovascular age-related macular degeneration (nAMD) treated with ranibizumab.在接受雷珠单抗治疗的新生血管性年龄相关性黄斑变性（nAMD）中，光学相干断层扫描（OCT）发现的意义不确定的结果作为预后因素。
Int J Retina Vitreous. 2022 Apr 21;8(1):29. doi: 10.1186/s40942-022-00379-z.
8
Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis.玻璃体内抗血管内皮生长因子疗法治疗新生血管性年龄相关性黄斑变性的比较效果：一项荟萃分析。
J Clin Med. 2022 Mar 25;11(7):1834. doi: 10.3390/jcm11071834.
9
Sex Hormones and Their Effects on Ocular Disorders and Pathophysiology: Current Aspects and Our Experience.性激素及其对眼部疾病和病理生理学的影响：当前的观点和我们的经验。
Int J Mol Sci. 2022 Mar 17;23(6):3269. doi: 10.3390/ijms23063269.
10
A Comparative Study of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes of Polish Therapeutic Program in Non-Tertiary Institution.雷珠单抗与阿柏西普治疗新生血管性年龄相关性黄斑变性的比较研究：非三级医疗机构波兰治疗方案的12个月结果
Cureus. 2021 Jun 25;13(6):e15916. doi: 10.7759/cureus.15916. eCollection 2021 Jun.

本文引用的文献

1
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.抑制年龄相关性脉络膜新生血管中 VEGF 的替代治疗：IVAN 随机对照试验的 2 年发现。
Lancet. 2013 Oct 12;382(9900):1258-67. doi: 10.1016/S0140-6736(13)61501-9. Epub 2013 Jul 19.
2
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.叶黄素+玉米黄质和欧米伽-3 脂肪酸治疗年龄相关性黄斑变性：年龄相关性眼病研究 2（AREDS2）随机临床试验。
JAMA. 2013 May 15;309(19):2005-15. doi: 10.1001/jama.2013.4997.
3
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。
Cochrane Database Syst Rev. 2012 Nov 14;11:CD000254. doi: 10.1002/14651858.CD000254.pub3.
4
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.玻璃体内注射阿柏西普（抗 VEGF 融合蛋白）治疗湿性年龄相关性黄斑变性。
Ophthalmology. 2012 Dec;119(12):2537-48. doi: 10.1016/j.ophtha.2012.09.006. Epub 2012 Oct 17.
5
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.雷珠单抗和贝伐单抗治疗新生血管性年龄相关性黄斑变性：两年结果。
Ophthalmology. 2012 Jul;119(7):1388-98. doi: 10.1016/j.ophtha.2012.03.053. Epub 2012 May 1.
6
Management of retinal vascular diseases: a patient-centric approach.视网膜血管疾病的管理：以患者为中心的方法。
Eye (Lond). 2012 Apr;26 Suppl 2(Suppl 2):S1-16. doi: 10.1038/eye.2012.32.
7
EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.EVEREST 研究：维替泊芬光动力疗法联合雷珠单抗或单用与雷珠单抗单药治疗有症状的黄斑息肉样脉络膜血管病变患者的疗效和安全性。
Retina. 2012 Sep;32(8):1453-64. doi: 10.1097/IAE.0b013e31824f91e8.
8
The estimated prevalence and incidence of late stage age related macular degeneration in the UK.英国晚期年龄相关性黄斑变性的估计患病率和发病率。
Br J Ophthalmol. 2012 May;96(5):752-6. doi: 10.1136/bjophthalmol-2011-301109. Epub 2012 Feb 13.
9
Multimodal imaging of dry age-related macular degeneration.干性年龄相关性黄斑变性的多模态影像学
Acta Ophthalmol. 2012 Jun;90(4):e281-7. doi: 10.1111/j.1755-3768.2011.02331.x. Epub 2012 Jan 23.
10
Does laser still have a role in the management of retinal vascular and neovascular diseases?激光在视网膜血管性和新生血管性疾病的治疗中是否仍有作用？
Am J Ophthalmol. 2011 Sep;152(3):332-339.e1. doi: 10.1016/j.ajo.2011.04.015. Epub 2011 Jul 13.